PharmaShots | Incisive News in 3 Shots

Subscribe Now

Lantheus

Lantheus Strengthens its Alzheimer’s Disease Pipeline Through the Acquisition of Meilleur Technologies

Lantheus Strengthens its Alzheimer’s Disease Pipeline Through the Acquisition of Meilleur Technologies

July 16, 2024

Lantheus Acquires Cerveau Technologies to Expands Imaging Pipeline into Alzheimer’s Disease

Lantheus Acquires Cerveau Technologies to Expands Imaging Pipeline into Alzheimer’s Disease

February 7, 2023

Lantheus Entered into an Exclusive License Agreements with POINT Biopharma to Commercialize PNT2002 and PNT2003

Lantheus Entered into an Exclusive License Agreements with POINT Biopharma to Commercialize PNT2002 and PNT2003

November 15, 2022

Lantheus Appointed Syntermed as the First Distributor of Pylarify AI in the US

Lantheus Appointed Syntermed as the First Distributor of Pylarify AI in the US

March 31, 2022

Insights+: The US FDA New Drug Approvals in May 2021

Insights+: The US FDA New Drug Approvals in May 2021

June 17, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us